Attovia Therapeutics (ATTO) vs Iambic Therapeutics (IAM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Attovia Therapeutics is the larger company by market cap ($690.3 million vs $621.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATTO | IAM |
|---|---|---|
| Share price | $15.10 | $13.11 |
| Market cap | $690.26M | $621.42M |
| 1-day change | -3.08% | -8.06% |
| EPS (TTM) | $-5.53 | $-2.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.00 | $25.00 |
| 52-week low | $12.94 | $9.60 |
| Distance from 52-week high | -46.07% | -47.56% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +186.09% | +107.86% |
| Average volume | 337.27K | 714.92K |
| Shares outstanding | 45.71M | 47.40M |
| Employees | 50 | 171 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Attovia Therapeutics
ATTO stock →Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 50 employees
About Iambic Therapeutics
IAM stock →Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 171 employees
ATTO vs IAM FAQ
Which is bigger, Attovia Therapeutics or Iambic Therapeutics?
Attovia Therapeutics (ATTO) is larger, with a market capitalization of $690.26M compared with $621.42M for Iambic Therapeutics (IAM).
Are Attovia Therapeutics and Iambic Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.